The most remarkable value that Negev Capital investment brought to our Company was the strengthening of our self-confidence. When you feel that an expert investment firm starts trusting in you, your team, your vision, your goals, your values, then your personality get stronger and what you thought at the beginning could be unachievable, now becomes achievable.
Knowledge and highly qualified professionals in the industry. We wouldn't be thinking and exploring different approaches within the industry, even going beyond mental health disorders, if it wasn't for the Negev Capital team.
Although it's a repeated sentence, I can use it with strong arguments: "the best is about to come for Biomind". Even being a young biotech company we have been taking small but firm steps with a clear and ambitious focus on becoming a pharmaceutical company, there is a lot of stigma behind psychedelic substances, and we believe that from our humble position we are helping the industry to reduce wrong interpretations about these compounds.
We are building a new concept where the power of psychedelics merge with the traditional pharma industry. It's time to make a shift in our minds, almost one eight of the global population is running out of time, "traditional", needs to be transformed to "useful", because what we really know today is that traditional antidepressants have failed. Biomind is now visible in the radars of the largest participants in the space and this is not by casualty, it's the result of hard work and a completely different approach that is bringing a huge opportunity to expand Biomind's current scope.
Leaving apart the monetary investment, the way we keep pushing every day, in a very challenging sector (science requires lot of time, same as clinical trials) where if you lack of creativity and perseverance, the chances of success are very limited, is because of someone that really understand the field, the business, the timelines and the human factor, among other variables, Negev Capital.